Literature DB >> 10698708

Cyclolinteinone, a sesterterpene from sponge Cacospongia linteiformis, prevents inducible nitric oxide synthase and inducible cyclo-oxygenase protein expression by blocking nuclear factor-kappaB activation in J774 macrophages.

F D'acquisto1, V Lanzotti, R Carnuccio.   

Abstract

We investigated the effect of cyclolinteinone, a sesterterpene from Caribbean sponge Cacospongia linteiformis, on inducible NO synthase (iNOS) and cyclo-oxygenase-2 (COX-2) protein expression in lipopolysaccharide (LPS)-stimulated J774 macrophages. Incubation of J774 cells with LPS (1 microgram/ml) caused an increase of both iNOS and COX-2 protein expression, which was prevented in a concentration-dependent fashion by cyclolinteinone (12.5, 25 and 50 microM). Electrophoretic mobility-shift assay indicated that cyclolinteinone blocked the activation of nuclear factor-kappaB (NF-kappaB), a transcription factor necessary for either iNOS or COX-2 induction. Cyclolinteinone also blocked disappearance of I(kappa)B-alpha from cytosolic fraction and nuclear translocation of NF-kappaB subunits p50 and p65. These results show that cyclolinteinone down-regulates iNOS and COX-2 protein expression by inhibiting NF-kappaB activation and suggest that it may represent a novel anti-inflammatory compound capable of controlling the excessive production of prostaglandins and nitric oxide occurring in several inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698708      PMCID: PMC1220914     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.

Authors:  S H Lee; E Soyoola; P Chanmugam; S Hart; W Sun; H Zhong; S Liou; D Simmons; D Hwang
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.

Authors:  P García Pastor; S De Rosa; A De Giulio; M Payá; M J Alcaraz
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages.

Authors:  F D'Acquisto; T Iuvone; L Rombolà; L Sautebin; M Di Rosa; R Carnuccio
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

4.  Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells.

Authors:  J A Maier; T Hla; T Maciag
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

5.  Modulation of acute inflammation by endogenous nitric oxide.

Authors:  A Ialenti; A Ianaro; S Moncada; M Di Rosa
Journal:  Eur J Pharmacol       Date:  1992-02-11       Impact factor: 4.432

6.  Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

Authors:  B S Fletcher; D A Kujubu; D M Perrin; H R Herschman
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

Review 7.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

8.  Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.

Authors:  K Yamamoto; T Arakawa; N Ueda; S Yamamoto
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

9.  Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions.

Authors:  J Sirois; L O Levy; D L Simmons; J S Richards
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Mark T Hamann
Journal:  Mar Biotechnol (NY)       Date:  2003-11-03       Impact factor: 3.619

2.  Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-kappaB by inhibiting both its nuclear localization and ability to bind DNA.

Authors:  V Haridas; C J Arntzen; J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

3.  Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Paola Di Meglio; Carlo Irace; Maria Savarese; Raffaele Sacchi; Maria Pia Cinelli; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-16       Impact factor: 3.000

4.  Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation.

Authors:  Inmaculada Posadas; Salvatore De Rosa; M Carmen Terencio; Miguel Payá; M José Alcaraz
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma.

Authors:  Jiali Zhang; Bin Peng
Journal:  BMC Cancer       Date:  2007-06-01       Impact factor: 4.430

6.  Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human Breast Cancer MCF-7 Cell Line.

Authors:  Susan Costantini; Giovanna Romano; Fabiola Rusolo; Francesca Capone; Eliana Guerriero; Giovanni Colonna; Adrianna Ianora; Gennaro Ciliberto; Maria Costantini
Journal:  Mediators Inflamm       Date:  2015-09-27       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.